Target intelligence / Profile preview

Campylobacter jejuni flagellum

Molecular classification
Other, Bacterial protein complex, Virulence factor
01

Overview

The Campylobacter jejuni flagellum is a complex, polar proteinaceous appendage that is essential for the bacterium's motility, chemotaxis, and ability to colonize the host gastrointestinal tract (Guerry, 2007). It consists of a basal body, a hook, and a filament composed of two major flagellins, FlaA and FlaB, which are uniquely modified by O-linked glycosylation (Lertsethtakarn et al., 2011). In addition to its role in locomotion, the flagellum acts as a specialized secretion system for virulence factors, such as Campylobacter invasion antigens (Cia), which are necessary for host cell entry and infection (Burnham & Hendrixson, 2018). Because motility is a strict requirement for C. jejuni pathogenesis, the flagellar apparatus is a primary target for the development of anti-virulence agents and vaccines (Hwang et al., 2012). Current therapeutic strategies focus on inhibiting the FlgS/FlgR regulatory system that controls flagellar expression or utilizing flagellin as a vaccine antigen to elicit protective immunity (Neal-McKinney & Konkel, 2012). However, the high degree of phase variation and structural diversity among strains remain significant hurdles for the development of universal treatments (Parkhill et al., 2000).

Other names
Flagellar apparatusFlagellar filamentFlagellinFlaAFlaB
02

Mechanism of action

Inhibition of flagellar assembly via disruption of the FlgS/FlgR two-component system; immune-mediated neutralization of motility; inhibition of flagellar-mediated protein secretion (T3SS).

03

Biological functions

OtherBacterial motilityChemotaxisProtein secretion
04

Disease associations

InfectionOther
05

Safety considerations

Antigenic variationPhase variationPotential for molecular mimicryRisk of selecting for non-motile pathogenic variants
06

Interacting drugs

Experimental FlgS inhibitors

2 more in the full profile.

07

Biomarkers

Anti-FlaA IgG antibodiesAnti-FlaA IgA antibodiesFlagellar protein detection in stool

Beyond the preview

Go deeper on Campylobacter jejuni flagellum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Campylobacter jejuni flagellum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call